Global Human Insulin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • ID:PD035405
  • October 2019
  • GIR (GlobalInfoResearch)
                          

The Global Human Insulin Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.

Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans.

Scope of the Report:
In 2018, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulatory framework for marketing approvals & medical reimbursements, continued expansion of advanced medical facilities in emerging countries (such as China & India), and rising public awareness related to benefits offered by human insulin in diabetes treatment.

The worldwide market for Human Insulin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019.

This report focuses on the Human Insulin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

  •     B. Braun
  •     Becton, Dickinson
  •     Biocon
  •     Biodel
  •     ELI Lilly
  •     Julphar
  •     NOVO Nordisk
  •     Sanofi
  •     Wockhardt
  •     Ypsomed

Market Segment by Regions, regional analysis covers
  •     North America (United States, Canada and Mexico)
  •     Europe (Germany, France, UK, Russia and Italy)
  •     Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  •     South America (Brazil, Argentina, Colombia etc.)
  •     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
  •     Insulin Analogs and Biosimilars
  •     Human Insulin Biologics

Market Segment by Applications, can be divided into
  •     Short acting
  •     Intermediate acting
  •     Long acting
  •     Pre-mix Insulin

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Insulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Insulin, with price, sales, revenue and global market share of Human Insulin in 2017 and 2018.
Chapter 3, the Human Insulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Insulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Human Insulin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Human Insulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Human Insulin Introduction
    1.2 Market Analysis by Type
        1.2.1 Insulin Analogs and Biosimilars
        1.2.2 Human Insulin Biologics
    1.3 Market Analysis by Applications
        1.3.1 Short acting
        1.3.2 Intermediate acting
        1.3.3 Long acting
        1.3.4 Pre-mix Insulin
    1.4 Market Analysis by Regions
        1.4.1 North America (United States, Canada and Mexico)
            1.4.1.1 United States Market States and Outlook (2014-2024)
            1.4.1.2 Canada Market States and Outlook (2014-2024)
            1.4.1.3 Mexico Market States and Outlook (2014-2024)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2014-2024)
            1.4.2.2 France Market States and Outlook (2014-2024)
            1.4.2.3 UK Market States and Outlook (2014-2024)
            1.4.2.4 Russia Market States and Outlook (2014-2024)
            1.4.2.5 Italy Market States and Outlook (2014-2024)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2014-2024)
            1.4.3.2 Japan Market States and Outlook (2014-2024)
            1.4.3.3 Korea Market States and Outlook (2014-2024)
            1.4.3.4 India Market States and Outlook (2014-2024)
            1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2014-2024)
            1.4.4.2 Egypt Market States and Outlook (2014-2024)
            1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
            1.4.4.4 South Africa Market States and Outlook (2014-2024)
            1.4.4.5 Turkey Market States and Outlook (2014-2024)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 B. Braun
        2.1.1 Business Overview
        2.1.2 Human Insulin Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 B. Braun Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.2 Becton, Dickinson
        2.2.1 Business Overview
        2.2.2 Human Insulin Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Becton, Dickinson Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.3 Biocon
        2.3.1 Business Overview
        2.3.2 Human Insulin Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 Biocon Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.4 Biodel
        2.4.1 Business Overview
        2.4.2 Human Insulin Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Biodel Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.5 ELI Lilly
        2.5.1 Business Overview
        2.5.2 Human Insulin Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 ELI Lilly Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.6 Julphar
        2.6.1 Business Overview
        2.6.2 Human Insulin Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 Julphar Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.7 NOVO Nordisk
        2.7.1 Business Overview
        2.7.2 Human Insulin Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 NOVO Nordisk Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.8 Sanofi
        2.8.1 Business Overview
        2.8.2 Human Insulin Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 Sanofi Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.9 Wockhardt
        2.9.1 Business Overview
        2.9.2 Human Insulin Type and Applications
            2.9.2.1 Product A
            2.9.2.2 Product B
        2.9.3 Wockhardt Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.10 Ypsomed
        2.10.1 Business Overview
        2.10.2 Human Insulin Type and Applications
            2.10.2.1 Product A
            2.10.2.2 Product B
        2.10.3 Ypsomed Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Human Insulin Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
    3.1 Global Human Insulin Sales and Market Share by Manufacturer (2017-2018)
    3.2 Global Human Insulin Revenue and Market Share by Manufacturer (2017-2018)
    3.3 Market Concentration Rate
        3.3.1 Top 3 Human Insulin Manufacturer Market Share in 2018
        3.3.2 Top 6 Human Insulin Manufacturer Market Share in 2018
    3.4 Market Competition Trend
4 Global Human Insulin Market Analysis by Regions
    4.1 Global Human Insulin Sales, Revenue and Market Share by Regions
        4.1.1 Global Human Insulin Sales and Market Share by Regions (2014-2019)
        4.1.2 Global Human Insulin Revenue and Market Share by Regions (2014-2019)
    4.2 North America Human Insulin  Sales and Growth Rate (2014-2019)
    4.3 Europe Human Insulin  Sales and Growth Rate (2014-2019)
    4.4 Asia-Pacific Human Insulin  Sales and Growth Rate (2014-2019)
    4.5 South America Human Insulin  Sales and Growth Rate (2014-2019)
    4.6 Middle East and Africa Human Insulin  Sales and Growth Rate (2014-2019)
5 North America Human Insulin by Country
    5.1 North America Human Insulin Sales, Revenue and Market Share by Country
        5.1.1 North America Human Insulin Sales and Market Share by Country (2014-2019)
        5.1.2 North America Human Insulin Revenue and Market Share by Country (2014-2019)
    5.2 United States Human Insulin Sales and Growth Rate (2014-2019)
    5.3 Canada Human Insulin Sales and Growth Rate (2014-2019)
    5.4 Mexico Human Insulin Sales and Growth Rate (2014-2019)
6 Europe Human Insulin by Country
    6.1 Europe Human Insulin Sales, Revenue and Market Share by Country
        6.1.1 Europe Human Insulin Sales and Market Share by Country (2014-2019)
        6.1.2 Europe Human Insulin Revenue and Market Share by Country (2014-2019)
    6.2 Germany Human Insulin Sales and Growth Rate (2014-2019)
    6.3 UK Human Insulin Sales and Growth Rate (2014-2019)
    6.4 France Human Insulin Sales and Growth Rate (2014-2019)
    6.5 Russia Human Insulin Sales and Growth Rate (2014-2019)
    6.6 Italy Human Insulin Sales and Growth Rate (2014-2019)
7 Asia-Pacific Human Insulin by Country
    7.1 Asia-Pacific Human Insulin Sales, Revenue and Market Share by Country
        7.1.1 Asia-Pacific Human Insulin Sales and Market Share by Country (2014-2019)
        7.1.2 Asia-Pacific Human Insulin Revenue and Market Share by Country (2014-2019)
    7.2 China Human Insulin Sales and Growth Rate (2014-2019)
    7.3 Japan Human Insulin Sales and Growth Rate (2014-2019)
    7.4 Korea Human Insulin Sales and Growth Rate (2014-2019)
    7.5 India Human Insulin Sales and Growth Rate (2014-2019)
    7.6 Southeast Asia Human Insulin Sales and Growth Rate (2014-2019)
8 South America Human Insulin by Country
    8.1 South America Human Insulin Sales, Revenue and Market Share by Country
        8.1.1 South America Human Insulin Sales and Market Share by Country (2014-2019)
        8.1.2 South America Human Insulin Revenue and Market Share by Country (2014-2019)
    8.2 Brazil Human Insulin Sales and Growth Rate (2014-2019)
    8.3 Argentina Human Insulin Sales and Growth Rate (2014-2019)
    8.4 Colombia Human Insulin Sales and Growth Rate (2014-2019)
9 Middle East and Africa Human Insulin by Countries
    9.1 Middle East and Africa Human Insulin Sales, Revenue and Market Share by Country
        9.1.1 Middle East and Africa Human Insulin Sales and Market Share by Country (2014-2019)
        9.1.2 Middle East and Africa Human Insulin Revenue and Market Share by Country (2014-2019)
    9.2 Saudi Arabia Human Insulin Sales and Growth Rate (2014-2019)
    9.3 Turkey Human Insulin Sales and Growth Rate (2014-2019)
    9.4 Egypt Human Insulin Sales and Growth Rate (2014-2019)
    9.5 Nigeria Human Insulin Sales and Growth Rate (2014-2019)
    9.6 South Africa Human Insulin Sales and Growth Rate (2014-2019)
10 Global Human Insulin Market Segment by Type
    10.1 Global Human Insulin Sales, Revenue and Market Share by Type (2014-2019)
        10.1.1 Global Human Insulin Sales and Market Share by Type (2014-2019)
        10.1.2 Global Human Insulin Revenue and Market Share by Type (2014-2019)
    10.2 Insulin Analogs and Biosimilars Sales Growth and Price
        10.2.1 Global Insulin Analogs and Biosimilars Sales Growth (2014-2019)
        10.2.2 Global Insulin Analogs and Biosimilars Price (2014-2019)
    10.3 Human Insulin Biologics Sales Growth and Price
        10.3.1 Global Human Insulin Biologics Sales Growth (2014-2019)
        10.3.2 Global Human Insulin Biologics Price (2014-2019)
11 Global Human Insulin Market Segment by Application
    11.1 Global Human Insulin Sales Market Share by Application (2014-2019)
    11.2 Short acting Sales Growth (2014-2019)
    11.3 Intermediate acting Sales Growth (2014-2019)
    11.4 Long acting Sales Growth (2014-2019)
    11.5 Pre-mix Insulin Sales Growth (2014-2019)
12 Human Insulin Market Forecast (2019-2024)
    12.1 Global Human Insulin Sales, Revenue and Growth Rate (2019-2024)
    12.2 Human Insulin Market Forecast by Regions (2019-2024)
        12.2.1 North America Human Insulin Market Forecast (2019-2024)
        12.2.2 Europe Human Insulin Market Forecast (2019-2024)
        12.2.3 Asia-Pacific Human Insulin Market Forecast (2019-2024)
        12.2.4 South America Human Insulin Market Forecast (2019-2024)
        12.2.5 Middle East and Africa Human Insulin Market Forecast (2019-2024)
    12.3 Human Insulin Market Forecast by Type (2019-2024)
        12.3.1 Global Human Insulin Sales Forecast by Type (2019-2024)
        12.3.2 Global Human Insulin Market Share Forecast by Type (2019-2024)
    12.4 Human Insulin Market Forecast by Application (2019-2024)
        12.4.1 Global Human Insulin Sales Forecast by Application (2019-2024)
        12.4.2 Global Human Insulin Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Data Source

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Insights, Forecast to 2025

Tigecycline Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Caffeine Market Insights, Forecast to 2025

Caffeine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast  read more..


Global Rabies Vaccine Market Insights, Forecast to 2025

Rabies Vaccine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in  read more..


Global High Acuity Care Information Systems Market Research Report

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin  read more..